CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression

被引：76
|
作者：
Kong, Yanan [1 ,2 ,3 ]
Yang, Lu [1 ,2 ,3 ]
Wei, Weidong [1 ,2 ,3 ]
Lyu, Ning [2 ,3 ,4 ]
Zou, Yutian [1 ,2 ,3 ]
Gao, Guanfeng [1 ,2 ,3 ]
Ou, Xueqi [1 ,2 ,3 ]
Xie, Xiaoming [1 ,2 ,3 ]
Tang, Hailin [1 ,2 ,3 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Dept Breast Oncol, 651 East Dongfeng Rd, Guangzhou, Guangdong, Peoples R China
[2] State Key Lab Oncol South China, 651 East Dongfeng Rd, Guangzhou, Guangdong, Peoples R China
[3] Collaborat Innovat Ctr Canc Med, 651 East Dongfeng Rd, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Minimally Invas Intervent Radiol, Canc Ctr, 651 East Dongfeng Rd, Guangzhou, Guangdong, Peoples R China
来源：
EPIGENOMICS | 2019年 / 11卷 / 10期
基金：
中国国家自然科学基金;
关键词：
ceRNAs; circPLK1; circRNAs; MiR-296-5p; miRNAs; PLK1; prognosis; therapy; triple-negative breast cancer; tumor occurrence and metastasis; POLO-LIKE KINASE; POTENTIAL THERAPEUTIC TARGET; SMALL-MOLECULE INHIBITOR; CIRCULAR RNAS; PROGNOSTIC-SIGNIFICANCE; PLK EXPRESSION; GROWTH; IDENTIFICATION; MARKER;
D O I：
10.2217/epi-2019-0093
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Aim: To investigate the role of circRNAs in triple-negative breast cancer (TNBC) and the underlying mechanisms. Materials & methods: We performed circRNA microarrays to explore the expression profiles of TNBC cell lines. Experiments in vitro and in vivo were conducted to explore the effects of circPLK1 on tumor proliferation and metastasis as well as the interaction between circPLK1, miR-296-5p and PLK1 in TNBC. Results & conclusion: CircPLK1 was significantly upregulated in TNBC and associated with poor survivals. CircPLK1 knockdown inhibited cell growth and invasion in vitro as well as tumor occurrence and metastasis in vivo. CircPLK1-miR-296-5p-PLK1 axis regulates tumor progression by ceRNA mechanism in TNBC, indicating that circPLK1 may serve as a prognostic factor and novel therapeutic target for TNBC.
引用
收藏
页码：1163 / 1176
页数：14
相关论文
共 50 条
  • [41] Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway
    Du, Chuang
    Zhang, Jianhua
    Zhang, Linfeng
    Zhang, Yingying
    Wang, Yan
    Li, Jingruo
    JOURNAL OF GENE MEDICINE, 2021, 23 (09)
  • [42] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells
    Zhang, Yang
    Wang, Lu
    Gao, Peng
    Sun, Zhiguo
    Li, Ning
    Lu, Yanqin
    Shen, Jianglun
    Sun, Jian
    Yang, Yiming
    Dai, Hao
    Cai, Haifeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (05) : 2343 - 2352
  • [43] CircFAM64A enhances cellular processes in triple-negative breast cancer by targeting the miR-149-5p/CDT1 axis
    Maimaiti, Yusufu
    Zhang, Ning
    Zhang, Yunke
    Zhou, Jing
    Song, Haiping
    Wang, Shuntao
    ENVIRONMENTAL TOXICOLOGY, 2022, 37 (05) : 1081 - 1092
  • [44] miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3
    Zhang, Bao
    Shetti, Dattatrya
    Fan, Conghui
    Wei, Kun
    BIOLOGICAL RESEARCH, 2019, 52 (1)
  • [45] Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer
    Wang, Y.
    Tahiri, H.
    Yang, C.
    Gu, M.
    Ruan, X.
    Hardy, P.
    CLIMACTERIC, 2023, 26 (01) : 64 - 71
  • [46] Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer
    Hong Yu
    Hui Li
    Hua Qian
    Xia Jiao
    Xiaowei Zhu
    Xiaoqin Jiang
    Guihong Dai
    Junxing Huang
    Medical Oncology, 2014, 31
  • [47] Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
    Ortolan, E.
    Appierto, V
    Silvestri, M.
    Miceli, R.
    Veneroni, S.
    Folli, S.
    Pruneri, G.
    Vingiani, A.
    Belfiore, A.
    Cappelletti, V
    Vismara, M.
    Dell'Angelo, F.
    De Cecco, L.
    Bianchi, G., V
    de Braud, F. G.
    Daidone, M. G.
    Di Cosimo, S.
    ESMO OPEN, 2021, 6 (02)
  • [48] miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer
    Lv, Zhi-Dong
    Kong, Bin
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Li, Fu-Nian
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (05) : 864 - 873
  • [49] Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p
    Cabral Calvano Filho, Carlos Marino
    Calvano-Mendes, Daniele Carvalho
    Carvalho, Katia Candido
    Maciel, Gustavo Arantes
    Ricci, Marcos Desiderio
    Torres, Ana Paula
    Filassi, Jose Roberto
    Baracat, Edmund Chada
    TUMOR BIOLOGY, 2014, 35 (08) : 7733 - 7741
  • [50] FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
    Hamurcu, Zuhal
    Kahraman, Nermin
    Ashour, Ahmed
    Ozpolat, Bulent
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 485 - 493
12345